The Effects Assessment of the Polygonatum Kingianum Extract on Endurance Performance and Anti-fatigue
- Conditions
- Fatigue
- Interventions
- Dietary Supplement: Placebo drinkDietary Supplement: Polygonatum kingianum extract drink
- Registration Number
- NCT05877677
- Lead Sponsor
- TCI Co., Ltd.
- Brief Summary
To assess the efficacy of polygonatum kingianum extract on endurance performance and anti-fatigue
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 50
- Healthy male aged 30-60 years old
- Must read and sign the informed consent form
- During the experiment, do not change the lifestyle and eating habits
- Cooperate not to engage in high-intensity exercise 48 hours before each experiment
- Subject who is not willing to participate in this study.
- People with serious diseases of heart, liver, kidney, endocrine and other organs (such as hypertension, diabetes, renal dysfunction and heart-related diseases) and mental patients
- People who have undergone surgery within 6 months or have lower limb injuries
- People who are allergic to Polygonatum kingianum extract
- Participate in other clinical trials related to anti-fatigue within four weeks of the trial
- Students who are currently taking courses taught by the principal investigator of this trial.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo drink Placebo drink consume 1 bottle per day Polygonatum kingianum extract drink Polygonatum kingianum extract drink consume 1 bottle per day
- Primary Outcome Measures
Name Time Method The change of blood PDE5 gene expression Day 0, day 14, day28 Fasting venous blood was sampled to measure the expression of PDE5 gene
The change of aerobic endurance Day 0, day 14, day28 3-min step test is used to assess aerobic endurance
The change of continuous attention performance Day 0, day 14, day28 Canon continuous attention software (Conners' Continuous Performance Test) is used to assess continuous attention performance
The change of concentration of testosterone in blood Day 0, day 14, day28 Fasting venous blood was sampled to measure concentrations of testosterone
- Secondary Outcome Measures
Name Time Method The change of blood nitric oxide (NO) Day 0, day 14, day28 Fasting venous blood was sampled to measure concentrations of nitric oxide
The change of self-assessment fatigue condition Day 0, day 14, day28 A 10 point likert scale was utilized to evaluate fatigue condition. The higher the score, the higher the fatigue level.
Trial Locations
- Locations (1)
National Pingtung University of Science and Technology
🇨🇳Pingtung, Taiwan